Development and Validation of Pretreatment Serum Total Bilirubin as a Biomarker to Predict the Clinical Outcomes in Primary Central Nervous System Lymphoma: A Multicenter Cohort Study

SIMPLE SUMMARY: The prognosis of patients with primary central nervous system lymphoma (PCNSL) is poor due to the high recurrence rate and lack of consensus on the optimal treatment for refractory or relapsed diseases. Despite having good prognostic scores, such as an MSKCC score or IELSG score, non...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Jiazhen, Li, Shengjie, Li, Danhui, Hua, Wei, Guo, Lin, Xia, Zuguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526312/
https://www.ncbi.nlm.nih.gov/pubmed/37760555
http://dx.doi.org/10.3390/cancers15184584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526312/
https://www.ncbi.nlm.nih.gov/pubmed/37760555
http://dx.doi.org/10.3390/cancers15184584

Ejemplares similares